REFINE: Regorafenib observational study in hepatocellular carcinoma

19/09/2017
27/03/2024
EU PAS number:
EUPAS20981
Study
Finalised
Documents
Study protocol
Initial protocol
English (999.78 KB - PDF) View document
Updated protocol
English (1.43 MB - PDF) View document
Study results
Study results
English (224.8 KB - PDF) View document
Study report
Study report
English (2.45 MB - PDF) View document
Other information